Seems like a lot of people are using NR now and probably even some serious players (hopefully). Manyf...rightfully pointed out that there are almost endless was to use and market such a product. I personally believe the reason for the NR study delay is that the product does not target any one testable area but many, perhaps even hundreds. I can see the difficulty in arragning NR studies. Results will be released and deals will arrise over time and eventually everything will be discovered and used hopefully. I wonder if CDXC will have any control over the order of which news is released, as it may help the stock if there was some coordinated effort. Probably already too late as the product is out there now and the tests have begun even within me. The news will start to trickle in and then I envision a snowball effect that will make NR or Niagen a household name. I never linked an exit strategy price to anything but technical analysis in the past, but this time I'm going to guage it on the household name concept. If I hear about it from my circle of people I'm out as by then it will have penatrated into our everday lives. Of course this in theory will not happen as the company should have been snatched up by a larger player by then. Wonder what price would statisfy Frost.
You are gilding the Lilly in my opinion. You say it "seems like". What evidence do you have that anyone except you is using the supplement. It is next to impossible even to find the one small fitness products company that is selling it. Let's wait and see how it goes. I am much more interested in seeing their upcoming financials. Unless the hype over the past year has turned the losses around I am out of here.
The past will not predict the future, nor will facts for this one (I.e. CDXC and NR). NR will get attention, the kind you don't need to advertise for, it's only a matter of time. If you feel like you don't have much time, take some NR and relax a little.